University of California San Francisco
Give to UCSF
Immunologist and UCSF Professor Emeritus Jeffrey Bluestone, PhD, has been elected to the National Academy of Sciences (NAS) – one of the highest honors bestowed on American scientists.
A traditional African psychedelic plant medicine called ibogaine is the blueprint for two new drug candidates that could treat addiction and depression.
UCSF is the first hospital in California to offer pharmacogenetic testing for smarter prescribing. Testing identifies genetic makeup and tailors medications to improve efficacy and avoid lethal drug reactions.
From birth, Samantha has had four surgeries for heart disease. Her last surgery was aided by a 3D-printed replica of her heart, providing a detailed understanding of her heart’s anatomy. The surgery’s success allowed the now 15-year-old to lead a more normal life.
Henry Bourne, MD, a long-time UCSF researcher who chronicled its rise to prominence in the 1970s, has died at the age of 83.
A hepatitis outbreak in children occurred after COVID-19 lockdowns eased in 2022. Sudden exposure to a multitude of viruses upon reopening may have triggered this response in a small group of children.
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
What is “social prescribing” and what is UCSF doing to promote it? UCSF experts address the health ramifications of social isolation.
A clinical trial showed that, rather than removing lymph nodes, leaving them intact could help immunotherapy activate tumor-fighting T cells in the lymph nodes.
A new digital tool helps to calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
